Stem Cells FDA’s January 2026 CMC Flexibility for Cell and Gene Therapies: What It Means for the ADSC Pipeline Read More » Oscar Tellez 06/23/2026 10:00 AM
Stem Cells Heart Failure and Adipose Stem Cells: The Phase II Evidence Physicians Are Watching Read More » Oscar Tellez 06/22/2026 10:00 AM
Stem Cells ALS and Adipose-Derived Stem Cells: The Intrathecal MSC Trial at Mayo Clinic Read More » Oscar Tellez 06/21/2026 10:00 AM
Stem Cells Crohn’s Disease and Adipose-Derived Stem Cells: What the Darvadstrocel Story Tells GI Physicians Read More » Oscar Tellez 06/20/2026 10:00 AM
Stem Cells Hope Biosciences and the TBI Trial: Autologous Adipose MSCs for Chronic Brain Injury (NCT05951777) Read More » Oscar Tellez 06/19/2026 10:00 AM
Stem Cells The Mayo Clinic Multiple System Atrophy Trial: What Physicians Need to Know (NCT05167721) Read More » Oscar Tellez 06/18/2026 10:00 AM
Stem Cells Active Clinical Trials Using Adipose-Derived MSCs: A 2026 Physician Reference Read More » Oscar Tellez 06/17/2026 10:00 AM
Stem Cells Adipose Banking and the Orthopedic Physician: Harvest Documentation, Consent, and the SB 1768 Scope Read More » Oscar Tellez 06/16/2026 10:00 AM
Stem Cells FDA Warning Letters in Regenerative Medicine: The Pattern Physicians Must Recognize Read More » Oscar Tellez 06/15/2026 10:00 AM
